PWS Outcomes Assessment Study
NCT04102839 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 59
Last updated 2024-11-04
Summary
This is a longitudinal study during which qualitative interviews will be conducted with caregivers of Soleno C601/C602 study subjects. There is an additional option for caregivers to collect video data of PWS patients doing specific activities of daily life.
The purpose of this study is to understand the real-world and nuanced impact of a potential therapeutic on individual PWS patients. The results of this study will complement the outcomes being captured during the Soleno C601/C602 clinical studies.
There is no treatment or intervention associated with this study.
Conditions
Interventions
- OTHER
-
Interview
Qualitative Interview
Sponsors & Collaborators
-
Casimir Trials
collaborator UNKNOWN -
Soleno Therapeutics, Inc.
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-07-15
- Primary Completion
- 2021-06-08
- Completion
- 2021-06-08
Countries
- United States
Study Locations
More Related Trials
-
An Open-Label Study of Oral NNZ-2591 in Prader-Willi Syndrome (PWS-001)
NCT05879614 ·Status: WITHDRAWN ·Phase: PHASE2
-
A 2-Part Study to Assess Efficacy, Safety and Tolerability of BMB-101 for the Treatment of Patients With Prader-Willi Syndrome.
NCT07266324 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study of CSTI-500 in Patients With Prader-Willi Syndrome
NCT07348601 ·Status: RECRUITING ·Phase: PHASE2
-
Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome
NCT05701774 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome
NCT03047980 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Long-term Interventional Follow-up Study of Children With Prader-Willi Syndrome Included in the OTBB3 Clinical Trial
NCT05032326 ·Status: RECRUITING ·Phase: PHASE3
-
Natural History and Advanced Genetic Study of Pyruvate Dehydrogenase Complex Deficiencies
NCT03056794 ·Status: RECRUITING
-
Study of Tesomet With Open-label Extension in Subjects With Prader-Willi Syndrome
NCT05198362 ·Status: WITHDRAWN ·Phase: PHASE2
-
Comprehensive Assessment of Reactions to Pharmacogenetics in Complex Care Patients
NCT07060300 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Phase 1/2 Study of Vorinostat Therapy in Niemann-Pick Disease, Type C1
NCT02124083 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of NM8074 in Soliris-Treated Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
NCT05731050 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
suPERficial Slow-flow Vascular malFORMations Treated With sirolimUS
NCT02509468 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating Barriers to Stroke Screening and Prevention in Children With Sickle Cell Disease
NCT03621826 ·Status: COMPLETED
-
A Pharmacokinetic and Safety Study of CSTI-500 in Subjects With Prader-Willi Syndrome
NCT05504395 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 3 Study to Evaluate Intravenous Trappsol(R) Cyclo(TM) in Pediatric and Adult Patients With Niemann-Pick Disease Type C1
NCT04860960 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
PROPEL - A Prospective Observational Patient Registry to Evaluate ENPP1 and ABCC6 Deficiency
NCT06302439 ·Status: RECRUITING
-
PREPL in Health and Disease
NCT02263781 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study of Sirolimus Therapy for Segmental Overgrowth Caused by Somatic PI3K Activation
NCT02428296 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Rimonabant on Weight Gain and Body Composition in Adults With Prader Willi Syndrome
NCT00603109 ·Status: TERMINATED ·Phase: PHASE3
-
The Brigance Assessment Of Individual Neurodevelopment In Young Children With Sickle Cell Disease- 2
NCT01123863 ·Status: COMPLETED
-
PRIME Care (PRecision Medicine In MEntal Health Care) 2.0
NCT04958824 ·Status: UNKNOWN ·Phase: PHASE4
-
A Cohort of Patients With Cystinosis : Compliance to Cysteamine and Neurological Complications
NCT02012114 ·Status: COMPLETED ·Phase: NA
-
Effects of Livoletide (AZP-531) on Food-related Behaviors in Patients With Prader-Willi Syndrome
NCT03790865 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Tracking Neurodegeneration in Early Wolfram Syndrome
NCT02455414 ·Status: COMPLETED
-
Evaluation of Behavior, Executive Function, Neurotransmitter Function and Genomic Expression Kuvan Nonresponders
NCT01274026 ·Status: COMPLETED